Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Future directions in transplantation

T E Mandel1

  • 1Transplantation Unit, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC.

The Medical Journal of Australia
|February 15, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pancreatic islet xenotransplantation: the potential for tolerance induction.

Immunology today·2000
Same author

Islet transplantation.

Transplantation proceedings·1999
Same author

Fetal islet xenotransplantation in rodents and primates.

Journal of molecular medicine (Berlin, Germany)·1999
Same author

Evidence that macrophages are required for T-cell infiltration and rejection of fetal pig pancreas xenografts in nonobese diabetic mice.

Transplantation·1998
Same author

Cyclophosphamide, but not CTLA4Ig, prolongs survival of fetal pig islet grafts in anti-T cell monoclonal antibody-treated NOD mice.

Xenotransplantation·1998
Same author

Pig islet xenografts are susceptible to "anti-pig" but not Gal alpha(1,3)Gal antibody plus complement in Gal o/o mice.

Journal of immunology (Baltimore, Md. : 1950)·1998
Same journal

Still Treating Yesterday's Risk? Reconsidering Antiviral Use for Mild-to-Moderate COVID-19 Cases in a Broadly Immune Population.

The Medical journal of Australia·2026
Same journal

Striving for Racial Equity in Oral Cancer Research: A Case Study.

The Medical journal of Australia·2026
Same journal

Progressing Cross-Sector Collaboration for People With Eating Disorders and Higher Weight: Priority Actions From an Expert Roundtable Using a Modified Nominal Group Technique.

The Medical journal of Australia·2026
Same journal

Self-Poisoning With Prazosin and Its Off-Label Use in Australia, 2014-2024: Analysis of NSW Poisons Information Centre Data.

The Medical journal of Australia·2026
Same journal

Drivers of Vaccine Uptake for Aboriginal and Torres Strait Islander Children to Inform Tailored Strategies: A Qualitative Study Exploring Health Service Provider Perspective.

The Medical journal of Australia·2026
Same journal

Four Urgent Actions for the Rights to Culturally Safe Breastfeeding for Aboriginal and Torres Strait Islander Mothers and Babies to Breastfeed in Neonatal Intensive Care Environments.

The Medical journal of Australia·2026
See all related articles

Organ transplantation offers life-saving treatments but faces ethical, legal, and economic hurdles. Advances in immunosuppression and xenografts aim to expand access to organ replacement therapy.

Area of Science:

  • Medical Science
  • Surgical Innovation

Background:

  • Organ transplantation is a vital treatment for end-stage organ failure.
  • Current transplantation practices face limitations in donor availability and long-term graft survival.

Purpose of the Study:

  • To explore the challenges and future directions in organ transplantation.
  • To highlight advancements in immunosuppression and the potential of xenografts.

Main Methods:

  • Review of current transplantation practices and limitations.
  • Discussion of ethical, legal, and economic considerations.
  • Exploration of emerging technologies like novel immunosuppression and xenotransplantation.

Main Results:

  • Transplantation is expanding, but ethical concerns regarding donor sources (fetal, infant, xenografts) persist.

Related Experiment Videos

  • Legal frameworks and economic factors significantly impact donor pool maximization and funding.
  • Experimental progress in immunosuppression may lead to graft tolerance, reducing reliance on chronic immunosuppressants.

    • Conclusions:

    • Xenografts are likely essential to meet the growing demand for organs.
    • Genetic engineering and cell-based therapies offer potential solutions for organ supply.
    • Overcoming current limitations is crucial to realizing the full potential of transplantation.